TARS logo

TARS

Tarsus Pharmaceuticals Inc.

$55.63
+$0.63(+1.15%)
40
Overall
--
Value
40
Tech
--
Quality
Market Cap
$2.32B
Volume
721.72K
52W Range
$31.36 - $59.76
Target Price
$74.57
Order:

Income Statement

MetricTrendChart
2020
Dec
2021
Dec
2022
Dec
2023
Dec
2024
Dec
REVENUE
Total Revenue
--$57.0M$25.8M$17.4M$183.0M
Total Revenue
--$57.0M$25.8M$17.4M$183.0M
COST OF GOODS SOLD
Cost of Revenue
--$2.1M$955.0K----
GROSS PROFIT
Gross Profit
--$55.0M$24.9M$15.9M$170.1M
OPERATING EXPENSES
Operating Expenses
$27.0M$69.2M$87.6M$159.0M$290.7M
Research & Development
$18.8M$41.7M$42.6M$50.3M$53.4M
Research Expense
$18.8M$41.7M$42.6M$50.3M$53.4M
Selling, General & Administrative
$8.2M$27.5M$44.9M$108.7M$237.3M
Selling & Marketing Expenses
------$9.4M$29.8M
General & Administrative Expenses
$8.2M$27.5M$44.9M$108.7M$237.3M
Depreciation & Amortization
$100.0K$300.0K$325.0K$744.0K$685.0K
Depreciation & Amortization
$100.0K$300.0K$325.0K----
Amortization
----$174.0K$4.1M$8.7M
Other Operating Expenses
$-217.0K$645.0K$813.0K----
OPERATING INCOME
Operating income
$-27.0M$-12.2M$-62.7M$-143.2M$-120.6M
EBITDA
$-26.9M$-13.5M$-59.7M$-131.8M$-106.9M
NON-OPERATING ITEMS
Interest Expense (Non-Operating)
----$2.1M$3.3M$7.8M
Intinc
$188.0K$36.0K$3.5M$10.3M$15.0M
Net Non-Operating Interest Income/Expense
$188.0K$36.0K$1.3M$7.0M$7.2M
Gain on Sale of Securities
--$-987.0K$-501.0K$376.0K$-792.0K
Other Income/Expense
$15.0K$1.7M$-683.0K$-274.0K$2.1M
Other Special Charges
--$-73.0K$86.0K$-102.0K$-1.4M
SPECIAL ITEMS
Special Income Charges
----$-955.0K----
Other Impairment Of Capital Assets
$15.0K$2.0K------
PRE-TAX INCOME
EBIT
$-27.0M$-13.8M$-60.0M$-132.7M$-108.1M
Pre-Tax Income
$-26.8M$-13.8M$-62.1M$-135.9M$-115.6M
INCOME TAX
Tax Provision
$1.0K$55.0K$-4.0K$-4.4M$-4.3M
NET INCOME
Net Income
$-26.8M$-13.8M$-62.1M$-135.9M$-115.6M
Net Income (Continuing Operations)
$-26.8M$-13.8M$-62.1M$-135.9M$-115.6M
Net Income (Discontinued Operations)
$-26.8M$-13.8M$-62.1M$-135.9M$-115.6M
Net Income (Common Stockholders)
$-26.8M$-13.8M$-62.1M$-135.9M$-115.6M
Normalized Income
--------$-119.8M
TOTALS
Total Expenses
$27.0M$71.3M$88.5M$159.0M$290.7M
SHARE & EPS DATA
Average Shares Outstanding
$6.2M$20.6M$24.6M$29.4M$37.6M
Average Shares Outstanding (Diluted)
--$20.6M$24.6M$29.4M$37.6M
Shares Outstanding
$20.5M$20.7M$26.7M$34.2M$38.4M
Basic EPS
$-4.32$-0.67$-2.52$-4.62$-3.07
Basic EPS (Continuing Operations)
$-4.32$-0.67$-2.52$-4.62$-3.07
Diluted EPS
$-4.32$-0.67$-2.52$-4.62$-3.07
Diluted EPS (Continuing Operations)
--$-0.67$-2.52$-4.62$-3.07
OTHER METRICS
Interest Expense Operating
----$1.9M----
Other Gand A
$8.2M$27.5M$44.9M$108.7M$237.3M
Rent And Landing Fees
--$2.1M------
Write Off
----$955.0K----

Financial data is updated quarterly and may not reflect the most recent earnings.

ABCD
1SymbolPriceChangeVol
2TARS$55.63+1.1%721.72K
3
4
5
6

Get Tarsus Pharmaceuticals Inc. Data in Excel

Stream real-time data directly to your spreadsheets

BUY NOW
Stock data provided by MarketXLS.